Literature DB >> 18226429

1,2,3,4-tetrahydro-2-thioxopyrimidine analogs of combretastatin-A4.

Lauren Lee1, Ryan Davis, Jenna Vanderham, Patrice Hills, Hilary Mackay, Toni Brown, Susan L Mooberry, Moses Lee.   

Abstract

Eleven 1,2,3,4-tetrahydro-2-thioxopyrimidine analogs of combretastatin-A4 (CA-4) were synthesized and their cytotoxicity against the growth of two murine cancer cell lines (B16 melanoma and L1210 leukemia) in culture was determined using an MTT assay. Two 2-thioxopyrimidine analogs 8f and 9a exhibited significant activity (IC50<1 microM for L1210 and <10 microM for B16 cells). Exposure of A-10 cells to 8f and 9a produced a significant reduction in cellular microtubules in interphase cells, with an EC50 value of 4.4 and 2.9 microM, respectively, for microtubule loss. Molecular modeling studies using MacSpartan indicated that the two active 2-thioxopyrimidine analogs preferably adopt a twisted conformation, similar to CA-4, affirming that conformation and structure are connected to activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18226429     DOI: 10.1016/j.ejmech.2007.11.030

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

Review 1.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

2.  A cellular model for screening neuronal nitric oxide synthase inhibitors.

Authors:  Jianguo Fang; Richard B Silverman
Journal:  Anal Biochem       Date:  2009-04-09       Impact factor: 3.365

3.  Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity.

Authors:  Qile Xu; Huan Qi; Maolin Sun; Daiying Zuo; Xuewei Jiang; Zhiyong Wen; Zhiwei Wang; Yingliang Wu; Weige Zhang
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

4.  Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation.

Authors:  Mohamed Hagras; Moshira A El Deeb; Heba S A Elzahabi; Eslam B Elkaeed; Ahmed B M Mehany; Ibrahim H Eissa
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 5.  Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review.

Authors:  Eavan C McLoughlin; Niamh M O'Boyle
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.